AstraZeneca Pharma reports 66 pct fall in net profit during Q2
- Country:
- India
Drug firm AstraZeneca Pharma India Tuesday reported a 66.65 per cent dip in its net profit to Rs 9.13 crore for the quarter ended September 30, 2018.
The company had posted a net profit of Rs 27.38 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Company's total revenue for the quarter under consideration stood at Rs 164.71 crore. It was Rs 166.75 crore for the same period year ago.
Shares of AstraZeneca Pharma India today closed at Rs 1,702.60 per scrip on BSE, up 0.70 per cent from the previous close.
ALSO READ
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
Cleaner Kitchens, Polluted Skies: Hidden Health Cost of India’s Electricity Boom
-
Japan-Backed ILO Projects Help 23,000 Workers Gain Rights and Fight Child Labour
-
India's Delicate Balancing Act: Navigating Energy Security Amid Middle Eastern Tensions
Google News